Share data Audited

Share data1

XLS

 

 

 

 

2008

2007

1

Share-price relevant figures relate to the closing price in Xetra® trading on the Frankfurt Stock Exchange.

2

The calculation of the theoretical number of shares is based on the fact that the general partner‘s equity capital is not represented by shares. As the share capital of € 168.0 million was divided into 64.6 million shares, the corresponding calculation for the general partner‘s capital of € 397.2 million resulted in 152.8 million theoretical shares on December 31, 2008.

3

Based on the theoretical number of shares.

Earnings per share after tax and minority interest
from continuing operations (in €)

1.69

–0.50

Earnings per share after tax and minority interest
from continuing and discontinued operations (in €)

1.69

16.21

Dividend in €

1.50

1.20

One-time bonus in €

2.00

Share price high in € (January 9, 2008/June 15, 2007)

93.79

106.55

Share price low in € (November 21, 2008/January 2, 2007)

57.67

79.96

Year-end share price in € 

64.51

88.30

Actual number of shares in millions (as of year-end)

64.6

64.6

Theoretical total number2 of shares in millions (as of year-end)

217.4

217.4

Market capitalization3 in € million (as of year-end)

14,024

19,196

Established in the DAX®

The liquidity of our shares remained at a high level in 2008. On average, 744,506 shares were traded daily. High liquidity makes Merck shares attractive for more investors. At the end of 2008, Merck again ranked 24th in the DAX® with respect to market capitalization, and 30th once again with respect to average share trading volumes.